xmab7195
mAbexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2014 (NCT02148744)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Immunoglobulin epsilon heavy chainINHIBITOR
Immunoglobulin epsilon heavy chain inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- xmab7195
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02881853 | Phase 1 | Aug 1, 2016 | ICON, Xencor |
| NCT02148744 | Phase 1 | May 1, 2014 | Parexel, Xencor |
Showing 2 of 2 trials
Page 1 / 1